tiprankstipranks
Trending News
More News >
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market

Pacira Pharmaceuticals (PCRX) Income Statement

Compare
376 Followers

Pacira Pharmaceuticals Income Statement

Last quarter (Q3 2025), Pacira Pharmaceuticals's total revenue was $179.52M, an increase of 6.49% from the same quarter last year. In Q3, Pacira Pharmaceuticals's net income was $5.43M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 700.97M$ 674.98M$ 666.82M$ 541.53M$ 429.65M
Gross Profit
$ 530.54M$ 490.31M$ 467.53M$ 401.28M$ 312.32M
Operating Expenses
$ 603.91M$ 402.63M$ 407.50M$ 311.35M$ 265.97M
Depreciation and Amortization
$ 78.78M$ 75.57M$ 91.50M$ 28.55M$ 19.91M
EBITDA
$ 29.12M$ 154.59M$ 140.38M$ 113.95M$ 63.51M
Operating Income
$ -73.37M$ 87.67M$ 60.02M$ 89.92M$ 46.35M
Other Income/Expenses
$ 10.27M$ -25.97M$ -46.72M$ -33.52M$ -26.26M
Pretax Income
$ -63.11M$ 61.70M$ 13.30M$ 56.40M$ 20.09M
Net Income
$ -99.56M$ 41.95M$ 15.91M$ 41.98M$ 145.52M
Per Share Metrics
Basic EPS
$ -2.15$ 0.91$ 0.35$ 0.95$ 3.41
Diluted EPS
$ -2.15$ 0.89$ 0.34$ 0.92$ 3.33
Weighted Average Shares Outstanding
46.24M 46.22M 45.52M 44.26M 42.67M
Weighted Average Shares Outstanding (Diluted)
46.24M 51.98M 46.54M 45.63M 43.68M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History